Table 4.
Distribution of C. acnes biotype | P value | |||||
---|---|---|---|---|---|---|
I | II | III | IV | V | ||
Erythromycin | ||||||
R (n = 31) | 2 | 6 | 15 | 2 | 6 | 0.163 (NS) |
S (n = 32) | 8 | 2 | 17 | 1 | 4 | |
Clindamycin | ||||||
R (n = 18) | 1 | 3 | 10 | 1 | 3 | 0.914 (NS) |
I (n = 8) | 1 | 1 | 4 | – | 2 | |
S (n = 37) | 8 | 4 | 18 | 2 | 5 | |
Moxifloxacin | ||||||
R (n = 4) | – | 1 | 2 | – | 1 | 0.750 (NS) |
S (n = 59) | 10 | 7 | 30 | 3 | 9 | |
MDR | ||||||
n = 3 | – | 1 | 1 | – | 1 |
Fisher’s exact test, significant at 0.05 level
R resistant, I intermediate, S susceptible, MDR multidrug-resistant, NS not significant